SCHEMBL12875147

SCHEMBL12875147

CC1(C(=O)Nc2ccc(CC(F)(F)F)cc2)CCN(Cc2ccccc2F)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.51
▸ KMT2A Q03164 5/20 0.51
▸ HTT P42858 2/20 0.51
▸ KDM4E B2RXH2 5/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ NPY2R P49146 1/20 0.45
▸ HPGD P15428 2/20 0.43
▸ SSTR5 P35346 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ DPP4 P27487 1/20 0.43
▸ DRD2 P14416 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ DCUN1D1 Q96GG9 1/20 0.42
▸ SIGMAR1 Q99720 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12874912 0.89 FAAH (0.48) MEN1KMT2AKDM4EALDH1A1SSTR5
SCHEMBL12874924 0.82 MEN1 (0.45) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL12875690 0.80 CHRNB2 (0.50) MEN1KMT2AALDH1A1MAPK1MAPT
SCHEMBL1146843 0.77 MEN1 (0.53) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL1147148 0.76 MEN1 (0.52) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL12875314 0.76 KDM4E (0.47) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL12874915 0.74 EPHX2 (0.52) KMT2AHTTALDH1A1NPY2RRAB9A
SCHEMBL1147265 0.74 P2RY1 (0.48) MEN1KMT2AHTTKDM4ENPY2R
SCHEMBL12875143 0.73 CNR2 (0.49) TP53
SCHEMBL1147231 0.73 MEN1 (0.51) MEN1KMT2AHTTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011012602-A1 PIPERIDINE DERIVATIVES AND THEIR USE TO TREAT OBESITY, DIABETES, DYSLIPIDEMIA AND ATHEROSCLEROSIS F. HOFFMANN-LA ROCHE AG (CH) 2011-02-03 — — WO disclosed
Send feedback